|Day Low/High||20.99 / 21.75|
|52 Wk Low/High||5.12 / 25.10|
In this day and age, companies must be 'disruptors' or get left in the dust.
Peltz's addition should pacify a persistent critique of the company.
I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.
Aurora Cannabis shares were indicated sharply higher Wednesday after it named billionaire activist investor Nelson Peltz as a strategic adviser to the Canada-based group.
Aurora's prominent partner could be cannabis' key to breaking into consumer segments.
Jim Cramer discusses Real Money's stock of the day and why he believes that the company is undervalued.
Vice stocks tend to do better than the wider market during economic downturns, as the U.S. economy slows down, cannabis could be the perfect safe haven. Watch.
Cronos is currently trading at 85 times forward EBITDA, more than double the multiple of some of its peers in the cannabis space.
Altria Group, Inc. (Altria) (NYSE:MO) announced today the completion of its approximately USD $1.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BNED, EGLE, JILL, SRCI Downgrades: CNX, DLTR, FSP Initiations: CRON, SAIL Read on to get TheStreet Quant Ratings' detailed report:
In its first report on cannabis companies, Melius says prices are high.
Cronos to sell its 19% stake in Whistler to Aurora Cannabis.
Jim Cramer lists the great stocks and the obvious winners he wishes he had talked about more.
The stock price of the cannabis company has been on a roll and is poised to move even higher still.
And why I won't recommend any other stocks in these markets, right now.
Jim Cramer says if you focus on what's going right, you'll sleep better and do a lot better with your money, too.
Jim Cramer weighs in on Waste Management, Weight Watchers, Centene, Aurinia Pharmaceuticals, Activision Blizzard, AbbVie, Cronos Group and more.
Jefferies gave five securities buy ratings in a note initiating coverage on the cannabis sector Monday.
Analyst Owen Bennett also says the market could rise to as high as $130 billion in 10 years.
Examining the influential short-sellers' big winners and losers provides important insights into trading and investing.
Searching Beyond Canopy Growth, Tilray and Cronos reveals a plethora of investment options with companies such as Valens GroWorks and others.
Jim Cramer sees ripple effects of a storm of IPOs, and is worried about the lack of money coming into the market.
Jim Cramer takes a closer look at Fitbit, Moderna, Tilray, Exelixis, Maxar Technology, International Paper and more.
Jim Cramer takes a closer look at Yeti Holdings, Cronos Group, Manitowoc, Crispr Therapeutics, Palo Alto Networks, Etsy and more.
Cramer's got the winners, the losers and the wild cards in the China trade brouhaha.
There are some big shifts Wednesday in names that have recently been the hottest.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.